New job opportunity
Artialis is looking for a Director of Industrialization & Production
Artialis has been nominated for the Deloitte Technology Fast 50!
Artialis has been nominated for Deloitte’s 2016 Technology Fast 50 competition for technology companies headquartered in Belgium.
Early phases and First-in-Man clinical trials
Artialis teams with ATC pharma to offer a complete solution of clinical trials in the field of joint health, including first-in-man studies.
“We chose Artialis because of their expertise in the design of in vivo protocol specialized in osteoarthritis. Moreover, it was very well written and Artialis team inspired a lot of confidence.
[We liked] their dedication to our project, their knowledge in osteoarthritis, their access to a state of the art animal facility, [and] their knowledge in in vivo design protocol (…) I would highly recommend the services of Artialis mainly for their high quality and high involvement.”
R&D Project Manager, Confidential Customer
Since the biomarker world is very competitive, every work involving new biomarkers should be previously and accurately discussed to tune the interests of the Sponsor with those of Artialis.
They are on time and flexible [and have] the ability to focus rapidly on the Sponsor requirement.
[We appreciate the] reliability of data and the open and timely communication.
Director Pharmacology & Toxicology, Rottapharm Biotech
We wanted to know whether oral treatment with polyphenols could decreased serum level of OA biomarkers in DMM mice model and needed results quickly. [Artialis has offered] robust skills, reactivity, and possibility to academic collaboration.
PhD candidate, INSERM U791, Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (France)